DR. ALEXANDRA ROGERS

DR. ALEXANDRA ROGERS

Alexandra Rogers, MD learned the need to adapt always at a young age with a Marine Corp Colonel and internist physician as parents. She received her undergraduate degree from Davidson College, where she graduated Cum Laude majoring in Art History and studying abroad in Kenya. While there she played Division 1 field hockey, captained the team and was an Academic All-American. This past competitive experience carries over to setting goals for patients and having a plan to accomplish them together.

 

She next graduated from Wake Forest Medical School. While there she was an Albert Schweitzer Fellow conducting a local education program to increase breastfeeding rates amongst low income minority women.  In addition, she received two NIH student research grants and a US-Brazil Infectious Disease Consortia Grant. She was awarded the Wake Forest University Women’s Excellence in Health Research Award for work performed in Mangalore, India on reducing antenatal HIV transmission. These opportunities both near and far confirmed a commitment to constantly adapt your skillset and reduce barriers that hinder care.  

 

After medical school Dr. Rogers was the first female trained at the Mayo Clinic Florida Urology residency program in Jacksonville. She earned two Mayo Clinic International Health Program Grants involving fistula repairs in Sierra Leone and prostate cancer treatment in Jamaica. She subsequently completed a fellowship in female urology and male voiding dysfunction at Cedars-Sinai Hospital. Since completing her fellowship in 2013, she has worked at Sansum Clinic in Santa Barbara. These broad exposures to different health care models have significantly influenced her desire to deliver highly effective therapies to all that are reproducible and require minimal resources.

 

She specializes in all aspects of both urinary and fecal incontinence. Areas of expertise include stress urinary incontinence solutions (Bulkamid® Urethral Injections & transobturator urethral slings) and fecal incontinence sacral neuromodulation surgery (Axonics®& Interstim® implants). In particular, she is dedicated to offering the best overactive bladder therapies including the safest beta agonist medications, sacral neuromodulation surgery (Axonics®& Interstim® implants), intravesical BOTOX® injections& Percutaneous Tibial Nerve Stimulation (Urgent PC®). She offers diagnostics such as cystoscopy and urodynamics. Also, she focuses on voiding dysfunction due to neurogenic conditions such as spinal cord injuries, Parkinson’s disease, strokes and multiple sclerosis. In addition, she manages pelvic organ prolapse (da Vinci® robotic sacrocolpopexy, vaginal repairs and pessary use), chronic urinary tract infections, bladder pain, hematuria, non-invasive bladder cancers and kidney stones (ESWL& Ureteroscopy).

 

Dr. Rogers has a focused research interest in tibial implants to treat OAB. She was an implantor for the eCoin FDA pivotal trial. This electroceutical coin (eCoin) investigational device is a nickel-sized, pacemaker-like device implanted into the lower leg to stimulate the tibial nerve.

 

She also tracks trends in OAB 3rd line penetration and the impact of novel therapy choices.  Between November 2019 to March 2020 Dr Rogers hit a 3rd line penetration rate of over 40% (national average ~<5%) demonstrating her dedication to effectively treating OAB. Despite the challenges of COVID, her 3rd line penetration rate has rebounded to pre-COVID levels.  In July 2020 Dr Rogers was recognized as an Axonics Center of Excellence for delivering high quality SNM therapy to patients suffering with fecal incontinence, urinary retention and OAB. Currently, Dr. Rogers is a top prescriber of Gemtesa in the United States. Improving access to this new medication is driven by a desire to provide an effective but safe choice to patients that have a meaningful response to a 2 week medication sample with special efforts to make Gemtesa as affordable as possible with prior authorization support and use of coupons for private PPO insurances.